BBP ETF Holdings

Holdings

Symbol	Grade	Price % Change	Allocation
TVTX	B	-0.05	3.67
ADMA	B	-0.56	2.92
TGTX	B	1.51	2.77
MIRM	B	2.87	2.41
EXEL	B	2.24	2.39
AUPH	B	1.03	2.32
ALNY	D	-0.77	2.24
TARS	B	3.97	2.16
GILD	C	0.48	2.11
LGND	B	2.27	2.10
RYTM	C	1.54	2.07
ZLAB	C	2.84	2.03
AXSM	B	0.50	2.01
UTHR	C	1.51	1.92
ITCI	C	0.28	1.86
INSM	C	-0.89	1.83
AGIO	C	0.25	1.78
TBPH	C	-1.46	1.77
BCRX	D	1.47	1.77
MDGL	B	5.53	1.73
INCY	C	1.89	1.72
BGNE	D	-2.08	1.72
BNTX	D	4.53	1.69
HRMY	D	2.53	1.67
ACAD	D	1.17	1.64
PTCT	B	0.79	1.63
ROIV	C	6.01	1.60
DAWN	F	2.85	1.60
RARE	D	2.65	1.60
DVAX	C	0.49	1.53
KRYS	B	4.45	1.49
ASND	D	5.85	1.49
SWTX	C	7.49	1.48
IOVA	F	3.76	1.48
VRTX	F	0.13	1.43
AMGN	D	1.60	1.43
YMAB	F	3.07	1.38
HALO	F	7.22	1.38
FOLD	F	1.68	1.37
BPMC	C	-2.56	1.36
NBIX	C	0.52	1.34
LEGN	F	2.99	1.34
PHAT	F	-1.16	1.31
SRPT	D	3.38	1.30
ESPR	C	2.02	1.27
IMCR	D	0.50	1.25
IONS	F	0.21	1.25
GERN	D	1.24	1.19
BBIO	F	0.77	1.19
ARDX	F	3.71	1.13
BMRN	D	1.28	1.12
REGN	F	-0.87	1.11
CRSP	D	3.43	1.10
APLS	D	10.88	1.04
BIIB	F	-0.07	1.02
IRWD	F	2.99	0.97
NVAX	F	5.35	0.81
LXRX	F	11.88	0.74
SAGE	F	6.60	0.65
MRNA	F	7.48	0.39

Represented by ETF Holdings

Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Development Infectious Diseases Biology Monoclonal Antibodies Nasdaq 100 Rare Diseases S&P 500 Chemical Compounds Diabetes Inflammation Organ Systems Pain Acid Alzheimer's Disease Autoimmune Disease

Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic

Recent News for BioShares Biotechnology Products Fund & its Holdings

Date	Stock	Title
Nov 23	INCY	What Moved Markets This Week
Nov 23	BBIO	Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
Nov 22	MRNA	Jefferies says market nears short term “peak RFK negativity", Vaccine makers up
Nov 22	MRNA	Goldman Sachs: Moderna, Inc. (NASDAQ:MRNA) Is A Top Growth Investor Stock
Nov 22	MRNA	Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference
Nov 22	SRPT	High Growth Tech Stocks to Watch in November 2024
Nov 22	MRNA	Moderna up 8% as Jefferies says market is close to 'peak RFK negativity'
Nov 22	HALO	Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook
Nov 22	HALO	Halozyme Therapeutics (HALO) Upgraded to Buy: Here's Why
Nov 22	MRNA	Moderna's Fresh Blow As RFK Heads To HHS - A Tough 2025 May Be In Store
Nov 22	IOVA	2 Innovative Stocks That Could Deliver Outsize Returns
Nov 22	MDGL	Madrigal (MDGL) Just Flashed Golden Cross Signal: Do You Buy?
Nov 22	HALO	Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
Nov 22	AMGN	Why Amgen (AMGN) is a Top Value Stock for the Long-Term
Nov 22	HALO	Halozyme shares jump 12% as it scraps $2.1 bln Evotec deal
Nov 22	HALO	Halozyme withdraws $2.1 billion buyout offer for Evotec
Nov 22	HALO	Halozyme gains after withdrawing Evotec bid
Nov 22	LXRX	Lexicon Pharmaceuticals to Cut 60% of Workforce
Nov 22	HALO	Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions
Nov 22	LXRX	Lexicon falls on restructuring program

The BioShares Biotechnology Products Fund (BBP) seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index.
Exchange Traded Fund ETF Biotechnology Technology Products Biotechnology Products

ETF Components for BBP - BioShares Biotechnology Products Fund